| 1 | Terns Pharmaceuticals Inc | 1 456 378 | 76,8 M $ | |
| 2 | Kodiak Sciences Inc | 1 265 795 | 48,3 M $ | |
| 3 | Alumis Inc | 1 213 548 | 26,7 M $ | |
| 4 | Vaxcyte Inc | 428 682 | 24,9 M $ | |
| 5 | Praxis Precision Medicines Inc | 71 581 | 23,1 M $ | |
| 6 | Harrow Inc | 543 047 | 19,1 M $ | |
| 7 | Relmada Therapeutics Inc | 2 688 359 | 18,7 M $ | |
| 8 | Cytokinetics Inc | 283 572 | 18,7 M $ | |
| 9 | Tenax Therapeutics Inc | 1 017 600 | 16,3 M $ | |
| 10 | Capricor Therapeutics Inc | 528 015 | 16,1 M $ | |
| 11 | Revolution Medicines Inc | 163 142 | 15,9 M $ | |
| 12 | Celldex Therapeutics Inc | 461 247 | 14,6 M $ | |
| 13 | Bridgebio Pharma Inc | 160 120 | 11,9 M $ | |
| 14 | Oruka Therapeutics Inc | 242 021 | 11,9 M $ | |
| 15 | Alto Neuroscience Inc | 515 000 | 11,6 M $ | |
| 16 | Soleno Therapeutics Inc | 344 123 | 11,5 M $ | |
| 17 | Maze Therapeutics Inc | 378 999 | 11,3 M $ | |
| 18 | ANI Pharmaceuticals Inc | 147 085 | 11,3 M $ | |
| 19 | Contineum Therapeutics Inc | 807 874 | 10,6 M $ | |
| 20 | Ultragenyx Pharmaceutical Inc | 482 571 | 10,1 M $ | |
| 21 | Ionis Pharmaceuticals Inc | 127 038 | 9,5 M $ | |
| 22 | Olema Pharmaceuticals Inc | 598 281 | 8,9 M $ | |
| 23 | DAMORA THERAPEUTICS INC | 335 710 | 8,7 M $ | |
| 24 | Palvella Therapeutics Inc | 64 626 | 8,1 M $ | |
| 25 | Fulcrum Therapeutics Inc | 1 049 161 | 8 M $ | |
| 26 | Vera Therapeutics Inc | 200 000 | 8 M $ | |
| 27 | SPRUCE BIOSCIENCES INC | 121 356 | 7,9 M $ | |
| 28 | Inventiva SACA | 1 429 101 | 7,8 M $ | |
| 29 | JADE BIOSCIENCES INC | 512 349 | 7,2 M $ | |
| 30 | Ocugen Inc | 3 962 972 | 7,2 M $ | |
| 31 | Ovid therapeutics Inc | 2 894 704 | 6,4 M $ | |
| 32 | Abivax SA | 57 635 | 6,2 M $ | |
| 33 | Eli Lilly & Co | 6 547 | 6 M $ | |
| 34 | PELTHOS THERAPEUTICS INC | 256 598 | 5,4 M $ | |
| 35 | Surrozen Inc | 173 107 | 5 M $ | |
| 36 | Tectonic Therapeutic Inc | 157 537 | 4,9 M $ | |
| 37 | Alector Inc | 2 082 606 | 4,5 M $ | |
| 38 | LEGEND BIOTECH CORP | 226 888 | 4,1 M $ | |
| 39 | Karyopharm Therapeutics Inc | 733 435 | 4,1 M $ | |
| 40 | Lipocine Inc | 508 556 | 4,1 M $ | |
| 41 | Delcath Systems Inc | 431 251 | 4 M $ | |
| 42 | Arvinas Inc | 358 257 | 3,8 M $ | |
| 43 | Compass Pathways plc | 675 000 | 3,7 M $ | |
| 44 | Invivyd Inc | 2 656 570 | 3,5 M $ | |
| 45 | Annexon Inc | 580 244 | 3,2 M $ | |
| 46 | Forte Biosciences Inc | 118 972 | 3,1 M $ | |
| 47 | Lexeo Therapeutics Inc | 513 011 | 2,9 M $ | |
| 48 | Vir Biotechnology Inc | 293 258 | 2,6 M $ | |
| 49 | NextCure Inc | 238 303 | 2,5 M $ | |
| 50 | Neumora Therapeutics Inc | 1 278 408 | 2,5 M $ | |
| 51 | Acumen Pharmaceuticals Inc | 1 053 797 | 2,5 M $ | |
| 52 | Cabaletta Bio Inc | 900 000 | 2,4 M $ | |
| 53 | BridgeBio Oncology Therapeutics Inc | 270 231 | 2,4 M $ | |
| 54 | Nuvalent Inc | 23 594 | 2,4 M $ | |
| 55 | DBV Technologies SA | 525 000 | 2,2 M $ | |
| 56 | Tarsus Pharmaceuticals Inc | 31 166 | 2,2 M $ | |
| 57 | KALARIS THERAPEUTICS INC | 360 000 | 2,1 M $ | |
| 58 | Anteris Technologies Global Corp | 366 571 | 2 M $ | |
| 59 | Solid Biosciences Inc | 264 409 | 1,9 M $ | |
| 60 | IBIO INC | 957 062 | 1,8 M $ | |
| 61 | Cumberland Pharmaceuticals Inc | 553 153 | 1,8 M $ | |
| 62 | Silence Therapeutics PLC | 865 784 | 1,7 M $ | |
| 63 | TRAWS PHARMA INC | 678 142 | 1,2 M $ | |
| 64 | Journey Medical Corp | 251 436 | 1,2 M $ | |
| 65 | Verastem Inc | 213 865 | 1,1 M $ | |
| 66 | Neuronetics Inc | 701 182 | 1 M $ | |
| 67 | Lyell Immunopharma Inc | 41 081 | 824,1 k $ | |
| 68 | PepGen Inc | 447 165 | 791,5 k $ | |
| 69 | Kezar Life Sciences Inc | 102 211 | 758,4 k $ | |
| 70 | IMMUNIC INC | 674 662 | 748,9 k $ | |
| 71 | CENTESSA PHARMACEUTICALS PLC | 18 113 | 719,4 k $ | |
| 72 | KalVista Pharmaceuticals Inc | 35 119 | 706,9 k $ | |
| 73 | Insmed Inc | 4 214 | 689,1 k $ | |
| 74 | ACADIA Pharmaceuticals Inc | 28 099 | 625,5 k $ | |
| 75 | Equillium Inc | 303 555 | 607,1 k $ | |
| 76 | Passage Bio Inc | 68 124 | 534,8 k $ | |
| 77 | Fractyl Health Inc | 1 100 000 | 503,6 k $ | |
| 78 | Palisade Bio Inc | 274 978 | 481,2 k $ | |
| 79 | Viking Therapeutics Inc | 9 717 | 316,2 k $ | |
| 80 | Sangamo Therapeutics Inc | 1 218 671 | 300,9 k $ | |
| 81 | VISTAGEN THERAPEUTICS INC | 519 077 | 296,7 k $ | |
| 82 | VERU INC | 133 517 | 295,1 k $ | |
| 83 | EVAXION A/S | 74 698 | 277,9 k $ | |
| 84 | LEXICON PHARMACEUTICALS INC | 164 674 | 256,9 k $ | |
| 85 | Adlai Nortye Ltd. | 33 899 | 234,6 k $ | |
| 86 | MacroGenics Inc | 74 893 | 216,4 k $ | |
| 87 | Voyager Therapeutics Inc | 53 063 | 204,8 k $ | |
| 88 | SENSEI BIOTHERAPEUTICS INC | 6 351 | 200,2 k $ | |
| 89 | NEUPHORIA THERAPEUTICS INC | 47 443 | 193,1 k $ | |
| 90 | VYNE THERAPEUTICS INC | 264 912 | 158,3 k $ | |
| 91 | HYPERLIQUID STRATEGIES INC | 30 001 | 152,7 k $ | |
| 92 | Cartesian Therapeutics Inc | 20 807 | 128 k $ | |
| 93 | PMV Pharmaceuticals Inc | 89 136 | 110,5 k $ | |
| 94 | CNS PHARMACEUTICALS INC | 45 830 | 110 k $ | |
| 95 | Compass Therapeutics Inc | 18 000 | 95,2 k $ | |
| 96 | IO BIOTECH INC | 1 386 565 | 81,4 k $ | |
| 97 | Rezolute Inc | 16 479 | 50,3 k $ | |
| 98 | MANGOCEUTICALS INC | 138 146 | 49,7 k $ | |
| 99 | SHUTTLE PHARMACEUTICALS HOLDINGS INC | 68 993 | 46,8 k $ | |
| 100 | AirSculpt Technologies Inc | 16 398 | 46,4 k $ | |